Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...

As allergy season approaches, it’s not just humans who suffer—our furry friends can also experience discomfort from pollen, ...

ARC101, a potential best-in-class T-cell engager that targets solid tumors expressing CLDN6, is being assessed in a ...

Results saw all 24 healthy volunteers who made it to the 72-week mark still had effective levels of dMAB in their systems.

While weight loss injections may be the current “wellness” trend, the LYMA Supplement may offer a simpler, more natural way ...